Villasanta-Gonzalez, Alejandro
Mora-Ortiz, Marina
Alcala-Diaz, Juan F.
Rivas-Garcia, Lorenzo
Torres-Peña, Jose D.
Lopez-Bascon, Asuncion
Calderon-Santiago, Monica
Arenas-Larriva, Antonio P.
Priego‑Capote, Feliciano
Malagon, Maria M.
Eichelmann, Fabian
Perez-Martinez, Pablo
Delgado-Lista, Javier
Schulze, Matthias B.
Camargo, Antonio
Lopez-Miranda, Jose
Clinical trials referenced in this document:
Documents that mention this clinical trial
Sex-specific differences in intestinal microbiota associated with cardiovascular diseases
https://doi.org/10.1186/s13293-024-00582-7
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
https://doi.org/10.1186/s12933-023-01933-1
Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
https://doi.org/10.1007/s00394-022-02854-7
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
https://doi.org/10.1007/s00394-022-03080-x
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
https://doi.org/10.1186/s12933-021-01260-3
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial
https://doi.org/10.1161/strokeaha.120.033214
CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics
https://doi.org/10.1016/j.ahj.2016.04.011
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
https://doi.org/10.1007/s00394-021-02676-z
Funding for this research was provided by:
Consejería de Salud y Familias, Junta de Andalucía (Consejería de Salud y Familias, Junta de Andalucía)
European Union NextGenerationEU/PRTR
Co-funded by the European Union
Ministerio de Ciencia e Innovación (AGL2012/39615, PCIN-2016-084, AGL2015-67896-P, PID2019-104362RB-I00)
Instituto de Salud Carlos III (PIE14/00005, PIE14/00031, ICI20/00069, CP14/00114, DTS19/00007, PI19/00299, PI22/00925)
Fundación Patrimonio Comunal Olivarero, Junta de Andalucía
Diputaciones de Jaén y Córdoba
Centro de Excelencia en Investigación sobre Aceite de Oliva y Salud and Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de España
Consejería de Innovación, Ciencia y Empresa, Junta de Andalucía
Article History
Received: 21 May 2023
Accepted: 21 July 2023
First Online: 3 August 2023
Declarations
:
: The current work was conducted within the framework of the Coronary Diet Intervention with Olive Oil and Cardiovascular Prevention Study (CORDIOPREV; Clinical trials.gov. Identifier: NCT00924937). The trial protocol was approved by the Reina Sofia University Hospital Ethics Committee, following the Helsinki declaration and good clinical practices. All the patients gave their written informed consent to participate in the study. The experimental protocol conformed to international ethical standards.
: Not applicable.
: The authors declare no competing financial interests.